Yang P, Chen X, Wen H, Yu M, Yu H, Wang L
BMC Immunol. 2025; 26(1):12.
PMID: 40038600
PMC: 11877881.
DOI: 10.1186/s12865-025-00694-8.
Hameed M, Daamen A, Hossain M, Coutermarsh-Ott S, Lipsky P, Weger-Lucarelli J
bioRxiv. 2024; .
PMID: 39416014
PMC: 11482886.
DOI: 10.1101/2024.10.10.617696.
Lin L, Zou J, Pei S, Huang W, Zhang Y, Zhao Z
Heliyon. 2024; 10(19):e37726.
PMID: 39391510
PMC: 11466559.
DOI: 10.1016/j.heliyon.2024.e37726.
Zhu J, Wang Y, Chang W, Malewska A, Napolitano F, Gahan J
Nat Methods. 2024; 21(10):1830-1842.
PMID: 39227721
DOI: 10.1038/s41592-024-02408-1.
Adani S, Mohd Ashari N, Johan M, Edinur H, Noor N, Hassan M
Cureus. 2024; 16(5):e60158.
PMID: 38868295
PMC: 11167514.
DOI: 10.7759/cureus.60158.
Increased Natural Killer (NK)-cell cytotoxicity and Trypanosoma cruzi-specific memory B cells in subjects with discordant serology for Chagas disease.
Elias M, Cesar G, Caputo M, De Rissio A, Alvarez M, Lococo B
Biochim Biophys Acta Mol Basis Dis. 2024; 1870(6):167237.
PMID: 38750768
PMC: 11185218.
DOI: 10.1016/j.bbadis.2024.167237.
Exploring the depths of IgG4: insights into autoimmunity and novel treatments.
Unlu S, Sanchez Navarro B, Cakan E, Berchtold D, Meleka Hanna R, Vural S
Front Immunol. 2024; 15:1346671.
PMID: 38698867
PMC: 11063302.
DOI: 10.3389/fimmu.2024.1346671.
Nano-formulated delivery of active ingredients from traditional Chinese herbal medicines for cancer immunotherapy.
Shang Q, Liu W, Leslie F, Yang J, Guo M, Sun M
Acta Pharm Sin B. 2024; 14(4):1525-1541.
PMID: 38572106
PMC: 10985040.
DOI: 10.1016/j.apsb.2023.12.008.
B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis.
Ulutekin C, Galli E, Schreiner B, Khademi M, Callegari I, Piehl F
Cell Rep Med. 2023; 5(1):101351.
PMID: 38134930
PMC: 10829729.
DOI: 10.1016/j.xcrm.2023.101351.
Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies.
Hou Y, Chen M, Bian Y, Zheng X, Tong R, Sun X
Acta Pharm Sin B. 2023; 13(8):3321-3338.
PMID: 37655334
PMC: 10465871.
DOI: 10.1016/j.apsb.2023.01.006.
Counteracting Immunosenescence-Which Therapeutic Strategies Are Promising?.
Hieber C, Grabbe S, Bros M
Biomolecules. 2023; 13(7).
PMID: 37509121
PMC: 10377144.
DOI: 10.3390/biom13071085.
Analysis of LC3-Associated Phagocytosis and Antigen Presentation in Macrophages and B Cells.
Nopper S, Schmidt K, Ligeon L, Munz C
Methods Mol Biol. 2023; 2692:311-336.
PMID: 37365477
DOI: 10.1007/978-1-0716-3338-0_21.
Transcriptomic analysis of B cells suggests that CD70 and LY9 may be novel features in patients with systemic lupus erythematosus.
Liu Q, Deng Y, Liu X, Zheng Y, Li Q, Cai G
Heliyon. 2023; 9(5):e15684.
PMID: 37144201
PMC: 10151360.
DOI: 10.1016/j.heliyon.2023.e15684.
TEDC2 correlated with prognosis and immune microenvironment in lung adenocarcinoma.
Fang L, Yu W, Zhu P, Yu G, Ye B
Sci Rep. 2023; 13(1):5006.
PMID: 36973475
PMC: 10042817.
DOI: 10.1038/s41598-023-32238-8.
Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy.
Yang C, Li D, Ko C, Wang K, Wang H
Front Immunol. 2023; 14:1133050.
PMID: 36969211
PMC: 10036358.
DOI: 10.3389/fimmu.2023.1133050.
The Multiple Facets and Disorders of B Cell Functions in Hepatitis B Virus Infection.
Ablikim D, Zeng X, Xu C, Zhao M, Yang X, Feng X
J Clin Med. 2023; 12(5).
PMID: 36902786
PMC: 10004556.
DOI: 10.3390/jcm12052000.
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited.
Dzobo K, Senthebane D, Dandara C
Cancers (Basel). 2023; 15(2).
PMID: 36672326
PMC: 9856874.
DOI: 10.3390/cancers15020376.
Human B-cell subset identification and changes in inflammatory diseases.
Velounias R, Tull T
Clin Exp Immunol. 2023; 210(3):201-216.
PMID: 36617261
PMC: 9985170.
DOI: 10.1093/cei/uxac104.
Immunomodulatory role of metalloproteases in cancers: Current progress and future trends.
Wang Q, Wang K, Tan X, Li Z, Wang H
Front Immunol. 2023; 13:1064033.
PMID: 36591235
PMC: 9800621.
DOI: 10.3389/fimmu.2022.1064033.
B cells in human lymphoid structures.
Montorsi L, Siu J, Spencer J
Clin Exp Immunol. 2022; 210(3):240-252.
PMID: 36370126
PMC: 9985168.
DOI: 10.1093/cei/uxac101.